Ashwin N Ananthakrishnan
Ashwin N Ananthakrishnan
Alan L Buchman
Alan L Buchman
Michelle Guan,Lin Chang
Michelle Guan
Irritable bowel syndrome (IBS) is currently diagnosed based on symptoms and limited diagnostic testing, highlighting the need for noninvasive biomarkers and personalized therapies. Emerging blood-based biomarkers such as cytolethal distendi...
Diksha Jha,Nidhi Singh,Govind Makharia
Diksha Jha
Celiac disease (CeD) is a multisystem autoimmune disease secondary to ingestion of gluten in genetically predisposed individuals. A precise and early diagnosis is essential for its effective and timely management. For comprehensive manageme...
Ji Yoon Yoon,Dan Li,Shailja C Shah
Ji Yoon Yoon
Gastric cancer (GC) is a major cause of preventable cancer death worldwide. Endoscopic screening is the gold standard for early detection, but due to logistical and cost barriers, organized efforts are limited to select high-incidence count...
Michelle Russin,Evan S Dellon
Michelle Russin
Eosinophilic esophagitis is a chronic, immune-mediated condition traditionally diagnosed and monitored through sedated endoscopy with biopsy. This invasive method, while essential, poses challenges for routine care. This article summarizes ...
Clinical Utility of Biomarkers for Barrett's Esophagus: Guidelines and Future Directions [0.03%]
巴雷特食管生物标志物临床应用指南及未来发展方向
Margaret J Zhou,Tarek Sawas,David A Leiman et al.
Margaret J Zhou et al.
Barrett's esophagus (BE) is a major risk factor for the development of esophageal adenocarcinoma (EAC) and is the only known precursor lesion for this lethal cancer. Although BE is relatively common among patients with gastroesophageal refl...
Biomarkers for the Diagnosis of Cirrhosis and Cirrhosis-Related Complications [0.03%]
用于诊断肝硬化和肝硬化相关并发症的生物标志物
Thomas Hunold,Rajalakshmi Govalan,Neehar Parikh
Thomas Hunold
Cirrhosis is an increasingly prevalent condition, with significant associated morbidity and mortality due to the development of several complications, including portal hypertension and hepatocellular carcinoma (HCC). Early detection of sign...
Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease [0.03%]
与代谢紊乱相关的肝脂肪变性疾病的生物标志物
Arka De,Naga Chalasani,Ajay Duseja
Arka De
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease globally, posing a significant public health challenge. Its progression from simple hepatic steatosis to metabolic dysf...
The Current Landscape of Microbial Biomarkers in Gastrointestinal Disease [0.03%]
肠道疾病中微生物生物标志物的最新研究进展
Sohn G Kim,Matthew Y Zhao,Christine Lam et al.
Sohn G Kim et al.
The intestinal microbiome encompasses a complex network of microorganisms that is now recognized to make wide contributions to health and disease but remains incompletely understood. Recent studies provide new insights into distinct roles o...